Anna Finley Caulfield, MD
Neurocritical care specialist
- Board Certification: Vascular Neurology, American Board of Psychiatry and Neurology (2008)
- Fellowship: Beth Israel Deaconess Medical Center Harvard Medical School (2004) MA
- BS, College of William & Mary, Biology (1994)
- Medical Education: Georgetown University (1999) DC
- Internship: Georgetown University Hospital (2000) DC
- Board Certification, Neurology, American Board of Psychiatry and Neurology (2004)
- Fellowship, Stanford University Medical Center, Neurocritical Care (2006)
- Residency: UCLA (2003) CA
- Board Certification: Neurocritical Care, United Council for Neurologic Subspecialties (2007)
Christine Anne Cunegonde Wijman, MD, PhD (1965-2013).
Finley Caulfield, A., & Venkatasubramanian, C. (2013). Christine Anne Cunegonde Wijman, MD, PhD (1965-2013). Neurocritical Care, 19(1), 135–136.
Metronidazole-Induced Encephalopathy: Not Always a Reversible Situation
Hobbs, K., Stern-Nezer, S., Buckwalter, M. S., Fischbein, N., & Caulfield, A. F. (2015). Metronidazole-Induced Encephalopathy: Not Always a Reversible Situation. NEUROCRITICAL CARE, 22(3), 429–436.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.